Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations
- 12 March 2008
- journal article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 17 (13), 1877-1889
- https://doi.org/10.1093/hmg/ddn083
Abstract
Mutations in the gene MPZ, encoding myelin protein zero (MPZ), cause inherited neuropathies collectively called Charcot–Marie–Tooth type 1B (CMT1B). Based on the age of onset, clinical and pathological features, most MPZ mutations are separable into two groups: one causing a severe, early-onset, demyelinating neuropathy and a second, causing a late-onset neuropathy with prominent axonal loss. To investigate potential pathomechanisms underlying the two phenotypes, we transiently transfected HeLa cells with two late-onset (T95M, H10P) and two early-onset (H52R, S22_W28 deletion) mutations and analyzed their effects on intracellular protein trafficking, glycosylation, cell viability and intercellular adhesion. We found that the two late-onset mutations were both transported to the cell membrane and moderately reduced MPZ-mediated intercellular adhesion. The two early-onset mutations caused two distinct abnormalities. H52R was correctly glycosylated and trafficked to the plasma membrane, but strongly affected intercellular adhesion. When co-expressed with wild-type MPZ (wtMPZ), a functional dominant negative effect was observed. Alternatively, S22_W28 deletion was retained within the cytoplasm and reduced both adhesion caused by wtMPZ and cellular viability. Since the same trafficking patterns were observed in transfected murine Schwann cells, they are not an artifact of heterologous cell expression. Our results suggest that at least some late-onset mutations cause a partial loss of function in the transfected cells, whereas multiple abnormal gain of function pathways can result in early-onset neuropathy. Further characterization of these pathways will lead to a better understanding of the pathogenesis of CMT1B and a rational basis for treating these debilitating inherited neuropathies.This publication has 30 references indexed in Scilit:
- Myelin protein zero/P0 phosphorylation and function require an adaptor protein linking it to RACK1 and PKCαThe Journal of cell biology, 2007
- Effect of an R69C Mutation in the Myelin Protein Zero Gene on Myelination and Ion Channel SubtypesArchives of Neurology, 2006
- Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutationsNature Genetics, 2004
- Phenotypic clustering in MPZ mutationsBrain, 2004
- Phenotypic Differences between Peripheral Myelin Protein-22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot-Marie-Tooth-Related DiseasesJournal of Neuropathology and Experimental Neurology, 2003
- Myelin P0: New Knowledge and New RolesNeurochemical Research, 2002
- Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelinationThe Journal of cell biology, 2001
- Myelin protein zero and membrane adhesionJournal of Neuroscience Research, 1998
- The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain.The Journal of cell biology, 1994
- Role of myelin Po protein as a homophilic adhesion moleculeNature, 1990